Featured Story | By Max Bayer Two years since its inception, Volastra Therapeutics is partnering with Bristol Myers Squibb for up to three oncology targets focused on chromosomal instability, a deal that could exceed $1.1 billion should the assets hit milestones. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Immunogen’s full data on mirvetuximab soravtansine have underwhelmed investors. While the biotech is racing to the FDA with the results, its stock fell around 20% to below $5 in premarket trading after the release of survival data that fell short of investor expectations. read more By Andrea Park,Conor Hale The medtech industry’s impressive venture funding activity was an anomaly in 2020, when most other sectors were floundering to stay afloat during the COVID-19 pandemic. A year later, as businesses around the globe returned to (somewhat) normal operations and overall VC activity hiked back up, medtech continued to ride that wave, coasting to its highest-ever annual funding total by the end of 2021. read more Sponsored by: Precision for Medicine To successfully advance preclinical biomarker assays from the bench to the bedside, it is crucial to develop a clear plan for delivering assays that can be used within the clinical trial setting. Learn strategies for assessing and optimizing biomarker feasibility and utility to support study success. read more By Nick Paul Taylor Bavarian Nordic has found a taker for the Chinese rights to its RSV vaccine candidate. Nuance Pharma has taken the other side of the deal, handing over $12.5 million and committing to $212.5 million more in milestones to license the vaccine in China, South Korea and some other markets in Southeast Asia. read more Sponsored by: PathAI Learn how Bristol Myers Squibb is unlocking new insights in translational research and development by transforming pathology with artificial intelligence read more By Angus Liu Inspired by a natural mechanism to protect bacteria, bioengineers at Columbia University have developed a programmable “cloaking” system that could temporarily hide bacterial vehicles from the immune system to better deliver cancer therapies. read more By Max Bayer Aeterna Zentaris has had to push recruitment plans for a phase 3 trial of a diagnostic test in children into 2023 due to Russia's war in Ukraine, the latest delay brought on by the conflict. read more By Eric Sagonowsky Pfizer has already made tens of billions of dollars in sales from its star COVID-19 vaccine, Comirnaty. For his work in steering the ship, the company's CEO Albert Bourla is cashing in, as well. read more By Ben Adams It’s March, so it’s time for some #FierceMadness. We’re looking for the best of the best in drug names—and now it's time to get voting for your Sweet 16. read more By Heather Landi The 10-day SXSW conference and festival brings together the worlds of tech, music and film and there were cutting-edge health tech innovations to check out as well. Here are innovations in healthcare, tech and wellness that caught our eye at SXSW 2022. read more By Sharon Klahr Coey On Tuesday, March 15, Equal Pay Day, Capital and Proxy Impact released the fifth Racial and Gender Pay Scorecard, and, surprise—women and people of color are still being paid less than their white male counterparts. read more By Dave Muoio Fierce Healthcare caught up with the CEO for a 2022 update on his company's shift from dialysis to kidney care, whether recent legal cases limit DaVita’s opportunities for growth and more. read more By Sophia Sorensen New research from UC Berkeley suggests disulfiram could be used to treat those with retinitis pigmentosa and other vision-impairing disorders. When tried with mice, the drug significantly improved their ability to recognize and respond to images. read more Resources Sponsored by: H1 Read why many MSLs are still challenged in developing integrated strategies to increase the volume of meaningful engagements. Download this industry report to find out what the top challenges are and suggestion strategies to solve them. Download now. Sponsored by: Medidata, a Dassault Systèmes company The landscape of clinical trials has been permanently changed. Today's trials require sponsors to modernize their use of technology and data to adapt. This eBook provides an overview of how sponsors can empower trials with real-time performance data to improve study integrity, reduce risks, optimize patient safety, and increase trial success rates. Sponsored by: Thermo Fisher Scientific Learn how to navigate the top manufacturing challenges and achieve a seamless transition from discovery to clinical manufacturing across the CAR T-cell therapy workflow. Sponsored by: Oracle Health Sciences Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research. Sponsored by: Oracle Health Sciences How to overcome top challenges faced in decentralized trials. Sponsored by: United Cargo The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent Biologics Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Fierce Promotional Review Committee Compliance and Best Practices Summit April 12-14, 2022 | New Brunswick, NJ Accelerating Immuno-Oncology and Oncology Drug Development Using Humanized Mice Live & Recorded on: Thursday, April 21, 2022 | 12pm ET / 9am PT Fierce Trial Master File Summit May 2-4, 2022 | New Orleans, LA & Streaming Live Fierce Digital Pharma Engage June 14-15, 2022 | Huntington Beach, CA Fierce Pharma PR & Communications Summit West June 14-15, 2022 | Huntington Beach, CA Fierce Digital Pharma Innovation Week June 21-23, 2022 | Virtual Event Fierce MedTech Summit August 8-9, 2022 | Minneapolis, MN Medical Affairs Strategic Summit (MASS West) September 2022 | San Diego, CA Promotional Review Committee Compliance and Best Practices Summit West (PRC West) September 2022 | San Diego, CA Fierce New Product Planning Summit September 20-22, 2022 | Boston, MA Fierce Digital Pharma East October 18-20, 2022 | Philadelphia, PA & October 25-28, 2022 | Virtual Event Fierce Pharma Marketing Awards October 19, 2022 | Philadelphia, PA Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Fierce Pharma Meeting Professionals Summit November 2-3, 2022 | Atlantic City, NJ Fierce European Trial Master File Summit November 14-16, 2022 | London, UK Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Virtual Event Fierce JPM Week 2023 January 2023 | San Francisco, CA & Virtual | 
